کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5666972 | 1591746 | 2017 | 6 صفحه PDF | دانلود رایگان |

- MDR Pseudomonas aeruginosa epidemic high-risk clones are widespread worldwide.
- The interplay between resistance and fitness cost remains unclear.
- Inflammatory response in P. aeruginosa infection was evaluated in an animal model.
- MDR strains elicited a lower inflammatory response than susceptible strains.
- These data suggest that MDR P. aeruginosa is associated with a fitness cost.
The increasing emergence of multidrug-resistant (MDR) Pseudomonas aeruginosa strains is associated with the spread of a few international epidemic clones called high-risk clones. The existence of a fitness cost associated with multidrug resistance remains unclear, and little is known about the host inflammatory response in acute P. aeruginosa infections. This study aimed to investigate how the inflammatory response occurs in the most relevant high-risk clones and to compare the process with that recorded in clinical susceptible isolates. Nine P. aeruginosa strains were studied, including the most relevant MDR high-risk clones (ST111, ST175 and ST235) circulating worldwide. The inflammatory response in terms of the release of interleukins in serum was investigated in a mouse peritonitis-sepsis model at three time points (4, 8 and 12âh). TNFα and interleukin-10 (IL-10) levels were significantly higher at all time points in mice inoculated with clinical susceptible strains compared with those inoculated with MDR strains. IL-6 levels were significantly higher in the clinical susceptible strain group at 8âh and 12âh (Pâ=â0.036 and Pâ=â0.007, respectively). Bacterial counts (log CFU/mL) in peritoneal fluid were higher in the clinical susceptible strain group compared with the MDR strain group at 8âh [6.00 (4.30-6.90) vs. 4.46 (3.30-5.34); Pâ=â0.005] and 12âh [7.75 (4.00-7.97) vs. 4.04 (2.58-4.94); Pâ=â0.003]. MDR P. aeruginosa strains elicited a weaker inflammatory response than susceptible strains in an experimental mouse model, suggesting the existence of a fitness cost associated with multidrug resistance.
Journal: International Journal of Antimicrobial Agents - Volume 49, Issue 2, February 2017, Pages 198-203